Laser medical device developer Abbott acquires AMO for $2.8 billion

On January 13th, Abbott, a world-renowned health care and medical research giant, announced that it had reached a definitive agreement to acquire Advanced Medical Optics (AMO). AMO has a leading position in ophthalmic care, ranking first in the field of laser ophthalmic correction surgical equipment and second in the field of cataract surgery equipment. The acquisition amounted to $2.8 billion, and the deal will give Abbott a long-term stable growth platform with an annual sales increase of $1 billion.

"With superior vision care technology and equipment, AMO has established its leadership position in the multi-billion dollar medical device market. Through AMO, Abbott has expanded its market for diverse medical devices and achieved its leading position," Miles D. White, president and CEO of Abbott, said, "In addition, Abbott's global organization will drive market growth, especially in the international market, where more people will use advanced eye care equipment and products."

Jim Mazzo, CEO and President of AMO, said: "The new strength will make Abbott's global market position more stable, and the ability to serve patients and health care workers will be greatly improved."

Compilation: Zeng Cong

The main ingredient of Tetanus Antitoxin is that horse tetanus immunboglobulin following pepsin digestion. It's used for the prophylaxsis and therapy of tetanus.

The ATS Injection (equine origin) is efficient and affordable for patients, which maket share covers over 70% of China, and it's expored to over 20 countries, especially to Afica, southeast Asia, South Asia. We offer an array of Tetanus Antitoxin Injection in different strength, there are 1500IU, 3000IU, 5000IU, 10000IU.

1500iu TAT

Antitoxin Formulations For Human

Antitoxin Formulations For Human,Tetanus Antitoxin,Tetanus Antitoxin Formulations,Antitoxin Formulations Essential Drug

Jiangxi Institute of Biological Products Inc. , https://www.jxinstitute.com

Posted on